Plunkett Research Online: GeneNews Ltd

GENENEWS LTD (GEN:TSE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

GeneNews Ltd. develops and markets diagnostic kits. The firm’s kits help diagnose cancer, cardiovascular diseases, central nervous system disorders, and arthritis from a blood sample......



GeneNews Ltd
Ticker: GEN
Exchange: TSE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 905 739-2030
Fax: 905 739-2031
Address: 445 Apple Creek Boulevard
Unit 220
Markham, ON L3R 9X7 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

In-Vitro Diagnostic Substance Manufacturing
ContactsDescription
James Howard-TrippCEO/Chairman of the Board/Director
Leslie AuldCFO/Treasurer/Director
See More
GeneNews Ltd. develops and markets diagnostic kits. The firm’s kits help diagnose cancer, cardiovascular diseases, central nervous system disorders, and arthritis from a blood sample......See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: